Home › Funds › Andera Partners › ABVX
Andera Partners position in ABVX
ABIVAX SA ADR · Health Care
Andera Partners reported holding 78,125 shares of ABVX (ABIVAX SA ADR) in its Q2 2026 13F filing — a position valued at US$10.4M, representing 5.04% of its reported portfolio and ranking #7 among its reported holdings. Andera Partners first reported this position in Q2 2026.
How Andera Partners's ABVX position evolved
Andera Partners first disclosed a stake in ABVX in Q2 2026 at 78,125 shares (US$10.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 78.12K | $10.41M | New |
About ABVX and 13F data
ABVX (ABIVAX SA ADR) is a Health Care company. 250 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$371.4M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABVX
- TCG Crossover Management, LLC 6.01M sh · $800.60M · Q2 2026
- Helikon Investments Ltd 2.79M sh · $371.41M · Q2 2026
- Darwin Global Management, Ltd. 3.62M sh · $348.22M · Q2 2026
- Vestal Point Capital, LP 2.35M sh · $313.09M · Q2 2026
- Jupiter Topco LLC 1.91M sh · $255.13M · Q2 2026
- Caligan Partners LP 1.56M sh · $207.61M · Q2 2026
- Morgan Stanley 1.43M sh · $190.85M · Q2 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.31M sh · $174.55M · Q2 2026
- Citadel Advisors 1.20M sh · $159.99M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 1.13M sh · $150.92M · Q2 2026
- Norges Bank Investment Management 1.10M sh · $146.59M · Q2 2026
- SUSQUEHANNA INTERNATIONAL GROUP, LLP 1.05M sh · $140.44M · Q2 2026